Log In
Print
BCIQ
Print
Print this Print this
 

Gilotrif, Giotrif, afatinib (Tomtovok) (BIBW 2992)

Also known as: Tovok

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionDual inhibitor of EGFR1 and HER2
Molecular Target Epidermal growth factor receptor 1 (EGFR1) (HER1) (ErbB1) ; Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of ActionEpidermal growth factor (EGF) receptor 2 (HER2) (ErbB2) (neu) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today